vs

Side-by-side financial comparison of MEDIFAST INC (MED) and MITEK SYSTEMS INC (MITK). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $44.2M, roughly 1.7× MITEK SYSTEMS INC). On growth, MITEK SYSTEMS INC posted the faster year-over-year revenue change (18.8% vs -36.9%). MITEK SYSTEMS INC produced more free cash flow last quarter ($6.6M vs $-6.6M). Over the past eight quarters, MITEK SYSTEMS INC's revenue compounded faster (-2.9% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Mitek Systems, Inc. is a software company that specializes in digital identity verification and mobile image processing using artificial intelligence. The company's software is used for depositing checks and opening bank accounts via mobile devices. It also verifies identity documents such as passports, ID cards, and driver's licenses by analyzing a selfie of an individual holding their ID, comparing their face to the photo on the document.

MED vs MITK — Head-to-Head

Bigger by revenue
MED
MED
1.7× larger
MED
$75.1M
$44.2M
MITK
Growing faster (revenue YoY)
MITK
MITK
+55.7% gap
MITK
18.8%
-36.9%
MED
More free cash flow
MITK
MITK
$13.2M more FCF
MITK
$6.6M
$-6.6M
MED
Faster 2-yr revenue CAGR
MITK
MITK
Annualised
MITK
-2.9%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
MITK
MITK
Revenue
$75.1M
$44.2M
Net Profit
$2.8M
Gross Margin
69.4%
Operating Margin
-10.4%
12.3%
Net Margin
6.3%
Revenue YoY
-36.9%
18.8%
Net Profit YoY
160.1%
EPS (diluted)
$-1.64
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
MITK
MITK
Q4 25
$75.1M
$44.2M
Q3 25
$89.4M
$44.8M
Q2 25
$105.6M
$45.7M
Q1 25
$115.7M
$51.9M
Q4 24
$119.0M
$37.3M
Q3 24
$140.2M
$43.2M
Q2 24
$168.6M
$45.0M
Q1 24
$174.7M
$47.0M
Net Profit
MED
MED
MITK
MITK
Q4 25
$2.8M
Q3 25
$-2.3M
$1.9M
Q2 25
$2.5M
$2.4M
Q1 25
$-772.0K
$9.2M
Q4 24
$-4.6M
Q3 24
$1.1M
$8.6M
Q2 24
$-8.2M
$216.0K
Q1 24
$8.3M
$282.0K
Gross Margin
MED
MED
MITK
MITK
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
MITK
MITK
Q4 25
-10.4%
12.3%
Q3 25
-4.6%
10.5%
Q2 25
-1.0%
8.3%
Q1 25
-1.1%
21.9%
Q4 24
0.6%
-8.3%
Q3 24
1.5%
17.8%
Q2 24
-4.7%
1.6%
Q1 24
4.5%
1.5%
Net Margin
MED
MED
MITK
MITK
Q4 25
6.3%
Q3 25
-2.5%
4.2%
Q2 25
2.3%
5.2%
Q1 25
-0.7%
17.6%
Q4 24
-12.4%
Q3 24
0.8%
19.8%
Q2 24
-4.8%
0.5%
Q1 24
4.8%
0.6%
EPS (diluted)
MED
MED
MITK
MITK
Q4 25
$-1.64
$0.06
Q3 25
$-0.21
$0.04
Q2 25
$0.22
$0.05
Q1 25
$-0.07
$0.20
Q4 24
$0.08
$-0.10
Q3 24
$0.10
$0.19
Q2 24
$-0.75
$0.00
Q1 24
$0.76
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
MITK
MITK
Cash + ST InvestmentsLiquidity on hand
$167.3M
$190.1M
Total DebtLower is stronger
$4.8M
Stockholders' EquityBook value
$198.9M
$233.7M
Total Assets
$248.0M
$446.5M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
MITK
MITK
Q4 25
$167.3M
$190.1M
Q3 25
$173.5M
$193.0M
Q2 25
$162.7M
$167.1M
Q1 25
$164.6M
$136.2M
Q4 24
$162.3M
$121.2M
Q3 24
$170.0M
$130.3M
Q2 24
$163.5M
$123.1M
Q1 24
$156.4M
$123.9M
Total Debt
MED
MED
MITK
MITK
Q4 25
$4.8M
Q3 25
$4.3M
Q2 25
Q1 25
Q4 24
Q3 24
$2.7M
Q2 24
Q1 24
Stockholders' Equity
MED
MED
MITK
MITK
Q4 25
$198.9M
$233.7M
Q3 25
$214.7M
$240.3M
Q2 25
$216.0M
$237.6M
Q1 25
$211.0M
$220.2M
Q4 24
$210.1M
$200.9M
Q3 24
$207.3M
$214.8M
Q2 24
$205.3M
$209.6M
Q1 24
$211.0M
$216.1M
Total Assets
MED
MED
MITK
MITK
Q4 25
$248.0M
$446.5M
Q3 25
$268.2M
$459.1M
Q2 25
$269.3M
$446.7M
Q1 25
$280.0M
$425.3M
Q4 24
$284.2M
$396.0M
Q3 24
$291.2M
$413.8M
Q2 24
$293.5M
$409.2M
Q1 24
$302.8M
$417.0M
Debt / Equity
MED
MED
MITK
MITK
Q4 25
0.02×
Q3 25
0.02×
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
MITK
MITK
Operating Cash FlowLast quarter
$-5.3M
$8.0M
Free Cash FlowOCF − Capex
$-6.6M
$6.6M
FCF MarginFCF / Revenue
-8.8%
14.9%
Capex IntensityCapex / Revenue
1.8%
3.2%
Cash ConversionOCF / Net Profit
2.89×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$60.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
MITK
MITK
Q4 25
$-5.3M
$8.0M
Q3 25
$12.1M
$19.5M
Q2 25
$-3.4M
$21.6M
Q1 25
$3.4M
$13.7M
Q4 24
$-4.9M
$565.0K
Q3 24
$9.1M
$21.1M
Q2 24
$13.1M
$13.0M
Q1 24
$7.3M
$7.1M
Free Cash Flow
MED
MED
MITK
MITK
Q4 25
$-6.6M
$6.6M
Q3 25
$10.8M
$19.2M
Q2 25
$-4.8M
$21.2M
Q1 25
$1.9M
$13.5M
Q4 24
$-7.2M
$230.0K
Q3 24
$7.7M
$20.8M
Q2 24
$11.1M
$12.6M
Q1 24
$5.4M
$6.6M
FCF Margin
MED
MED
MITK
MITK
Q4 25
-8.8%
14.9%
Q3 25
12.0%
42.9%
Q2 25
-4.5%
46.5%
Q1 25
1.6%
26.0%
Q4 24
-6.1%
0.6%
Q3 24
5.5%
48.2%
Q2 24
6.6%
27.9%
Q1 24
3.1%
14.0%
Capex Intensity
MED
MED
MITK
MITK
Q4 25
1.8%
3.2%
Q3 25
1.5%
0.6%
Q2 25
1.3%
0.7%
Q1 25
1.3%
0.4%
Q4 24
1.9%
0.9%
Q3 24
1.0%
0.7%
Q2 24
1.1%
1.0%
Q1 24
1.1%
1.0%
Cash Conversion
MED
MED
MITK
MITK
Q4 25
2.89×
Q3 25
10.46×
Q2 25
-1.36×
9.00×
Q1 25
1.50×
Q4 24
Q3 24
8.04×
2.46×
Q2 24
60.12×
Q1 24
0.88×
25.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

MITK
MITK

Fraud And Identity Solutions$25.5M58%
License$13.9M31%
Fraud And Identity Solutions Software License And Support$3.9M9%
Professional Services And Other$1.2M3%

Related Comparisons